Anbio Biotechnology (NNNN:NASDAQ) closed at $3.81 on October 23, 2026, up 2.70% on the day. The stock trades 91.5% below its 52-week high of $44.73 and 23.3% above its 52-week low of $3.09. Over the past year, it lost 83.4%. Anbio Biotechnology is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, NNNN closed higher on 112 days (44%). Its best day was November 5, 2025 (+57.48%) and its worst was November 3, 2025 (-27.06%). The stock moved 10% or more in a single session 40 times.
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs. Our comprehensive range encompasses solutions for various applications, including over-the-counter utilization, point-of-care settings, and laboratory applications. Our IVD products are designed to detect a wide range of biomarkers associated with critical medical domains. These domains encompass infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes.
Find more stocks like NNNN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.